Wugen

0 followers

‌

Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.

Industries

Headquarters

Stage

Employees

Links

Org chart

Kumar Srinivasan

President & CEO

Kumar Srinivasan

Collapse

Ayman Kabakibi

COO & EVP, R&D

Jan Davidson

CMO

Brunda Tumala

Director CMC Process Development

Chupei Zhang

Director

Jonathan Miller

Sr. Director, Head Of Supply Chain & Procurement

Kenneth Jacobs

VP Pharmacovigilance And Clinical Development

Laura Simpson PhD

Vp, Head Of Regulatory Affairs

Matthew Cooper

Chief Scientific Officer

Patrick Valme

Director Of Information Technology

Preeta Dasgupta

Senior Director Regulatory Affairs

Rachel Langland

Director, Analytical Development

Sarah Perdue

Associate Director, Operational Excellence

Carol Weiss

Senior Director, Quality Assurance

Jimmy Pham

Senior Associate Scientist

Keith Vendola

Chief Financial Officer

Teams

+15

Research and Development Scientists

18 members

Clinical and Regulatory Affairs

7 members

Leadership Team

4 members

Research and Development

5 members

Finance and Operations

5 members

Advisory Roles

4 members

Similar companies

Assembly Biosciences

9 followers

Adverum Biotech

8 followers

REVOLUTION Medicines

5 followers

MindMed

4 followers

Dyne Therapeutics

3 followers

Maze Therapeutics

1 follower

Cidara Therapeutics

1 follower

Abeona Therapeutics

1 follower

BioLabs

1 follower

Verastem

1 follower

Repertoire Immune Medicines

2 followers

Discover companies